Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>
The revival of DeltaRex-G (formerly Rexin-G)¿the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history¿returned active tumor surveillance and a precision-guided ¿silver bullet¿ (dnG1 killer gene) to the cancer clinic with ¿Expanded Access¿ in 2019. Empowered by US Right-to-Try legislation, while honoring ethical principles of ¿informed consent,¿ this unique graphic/picturesque presentation of clinical and translational medicine is intended for postmodern (post-Enlightenment) layman readers, including cancer patients, students, researchers, and future practitioners in the field of precision gene-based medicine. Confronting logical fallacies in popular opinion, the authors present newsworthy, up-to-date clinical research documenting the successful management of refractory metastatic cancers with tumor-targeted gene therapy vectors¿validating ¿pathotropic¿ (disease-seeking) tumor targeting avant la lettre.
Autorius: | Erlinda M. Gordon, Frederick Hall, |
Leidėjas: | IntechOpen |
Išleidimo metai: | 2021 |
Knygos puslapių skaičius: | 56 |
ISBN-10: | 1839694157 |
ISBN-13: | 9781839694158 |
Formatas: | 266 x 185 x 9 mm. Knyga kietu viršeliu |
Kalba: | Anglų |
Parašykite atsiliepimą apie „Our Journey Beyond Sunset Boulevard: Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on ¿True¿ Long-Term Cancer-Free Survival“